BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23984337)

  • 1. Antigenicity and immunogenicity of rotavirus VP6 protein expressed on the surface of Lactococcus lactis.
    Esteban LE; Temprana CF; Argüelles MH; Glikmann G; Castello AA
    Biomed Res Int; 2013; 2013():298598. PubMed ID: 23984337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model.
    Temprana CF; Argüelles MH; Gutierrez NM; Barril PA; Esteban LE; Silvestre D; Mandile MG; Glikmann G; Castello AA
    PLoS One; 2018; 13(9):e0203700. PubMed ID: 30192869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice.
    Perez CA; Eichwald C; Burrone O; Mendoza D
    J Appl Microbiol; 2005; 99(5):1158-64. PubMed ID: 16238746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Immunogenic Response in BALB/c Mice by Live and Killed Form of Recombinant Lactococcus lactis Displaying EG95 of Echinococcus granulosus.
    Ebrahimzadeh F; Shirdast H; Taromchi A; Talebkhan Y; Haniloo A; Esmaeilzadeh A; Nedaei K; Mirabzadeh E
    Iran Biomed J; 2021 Jul; 25(4):284-96. PubMed ID: 34217159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembling Rotavirus VP6 Nanoparticle Vaccines Expressed in Escherichia coli Elicit Systemic and Mucosal Responses in Mice.
    Li Z; Cui K; Huang K; Liu F; Shi D; Liu Q
    Protein Pept Lett; 2019; 26(12):904-909. PubMed ID: 31429685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.
    Lappalainen S; Tamminen K; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2013 Sep; 9(9):1991-2001. PubMed ID: 23777748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
    Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice.
    Marelli B; Perez AR; Banchio C; de Mendoza D; Magni C
    J Virol Methods; 2011 Jul; 175(1):28-37. PubMed ID: 21530589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.
    Malm M; Heinimäki S; Vesikari T; Blazevic V
    Clin Exp Immunol; 2017 Sep; 189(3):331-341. PubMed ID: 28407442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production.
    Li YJ; Ma GP; Li GW; Qiao XY; Ge JW; Tang LJ; Liu M; Liu LW
    J Biomed Biotechnol; 2010; 2010():708460. PubMed ID: 20625406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone.
    Afchangi A; Arashkia A; Shahosseini Z; Jalilvand S; Marashi SM; Roohvand F; Mohajel N; Shoja Z
    Viral Immunol; 2018 Apr; 31(3):233-241. PubMed ID: 29185875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4
    Heinimäki S; Malm M; Vesikari T; Blazevic V
    Antiviral Res; 2018 Sep; 157():1-8. PubMed ID: 29935205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of the main structural antigen VP6 of human rotavirus by recombinant adenovirus and immune responses induced in vivo].
    He J; Wang J; Jiang X; Wang D; Wen L; Dong J; Qu J; Hong T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):109-13. PubMed ID: 12196818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.
    McNeal MM; Stone SC; Basu M; Bean JA; Clements JD; Hendrickson BA; Choi AH; Ward RL
    Virology; 2006 Mar; 346(2):338-47. PubMed ID: 16375942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis.
    Li PC; Qiao XW; Zheng QS; Hou JB
    Vaccine; 2016 Jan; 34(5):696-702. PubMed ID: 26372858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.
    Choi AH; McNeal MM; Basu M; Flint JA; Stone SC; Clements JD; Bean JA; Poe SA; VanCott JL; Ward RL
    Vaccine; 2002 Sep; 20(27-28):3310-21. PubMed ID: 12213401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the immunogenicity of a recombinant HSV-1 vector expressing human group C rotavirus VP6 protein.
    Rota RP; Palacios CA; Temprana CF; Argüelles MH; Mandile MG; Mattion N; Laimbacher AS; Fraefel C; Castello AA; Glikmann G
    J Virol Methods; 2018 Jun; 256():24-31. PubMed ID: 29496429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).
    Smiley KL; McNeal MM; Basu M; Choi AH; Clements JD; Ward RL
    J Virol; 2007 Apr; 81(8):3740-8. PubMed ID: 17251301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Lactococcus Lactis Displaying Omp31 Antigen of Brucella melitensis Can Induce an Immunogenic Response in BALB/c Mice.
    Shirdast H; Ebrahimzadeh F; Taromchi AH; Mortazavi Y; Esmaeilzadeh A; Sekhavati MH; Nedaei K; Mirabzadeh E
    Probiotics Antimicrob Proteins; 2021 Feb; 13(1):80-89. PubMed ID: 32661939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.